Roche provides blood screening and diagnostic tests used worldwide to improve blood and blood product safety, diagnose disease, monitor progression and response to therapy, and identify gene‑based factors to aid in treatment selection. Roche's fully automated, real‑time PCR cobas s 201 system and the multiplex blood screening test for HIV‑1, HIV‑2, HCV and HBV ‑ the most comprehensive multiplex NAT test available ‑ enable improved blood safety and workflow efficiency. http://molecular.roche.com/blood_screening

The Binding Site Ltd is a British manufacturing company specialising in the development and production of high quality immunology diagnostic assays and reagents. In recent years the Binding Site has worked closely with our customers to develop assays with applications specific to industry. These include assays to measure high levels of Tetanus IgG and Varicella-zoster IgG during the screening of plasma donor units. Previously clinical range assays had to be adapted by the customer for this purpose. As specialists in the detection of serum and plasma proteins, the Binding Site also has a wide variety of research reagents and control fluids available. Our experience in producing and supplying specific antisera for both manufacture of our own diagnostic assays, and those of other manufacturers, enables us optimise these reagents if necessary.

For more information visit http://www.bindingsite.co.uk/antigenspecific-372.asp or come and see us at our exhibition stand.

A pioneer in transfusion medicine, Fenwal Inc. is one of the world’s largest suppliers of advanced technologies that help ensure a safe and plentiful global blood supply. With a singular focus on transfusion medicine, the newly independent Fenwal reignites its passion and commitment to helping is customers save and improve lives. Building on our nearly 60-year heritage of developing innovative solutions to meet the needs of blood and plasma centers, donors and recipients, our global team is focused on the research and development, manufacturing and marketing of innovative products for the collection, processing and storage of blood and blood components. For more information visit www.fenwalinc.com.

Sepa-Sigma, Inc. is a Japanese manufacturer of plain-type virus filters. Our 20nm filters superposed with 80nm membrane have excellent plasma protein transmissibility together with a higher removability of 20nm-size viruses. Its membrane is composed of regenerated cellulose with multi-layered (ca. 200-300 layers) structure and the filters are operated below 3 bar. We provide filters with 5 cm2 for virus clearance studies, 0.01 for protein transmissibility studies, 0.1, 0.5, 1 and 3 m2 for production scale. We also provide the integrity test of iron hydroxide colloid that is based on a direct method and non-destructive to the membranes. For more information visit http://www.sepa-sigma.com/

MAK-SYSTEM is a world leader in developing WEB-enabled software solutions for managing Blood Banking and Blood Transfusion activities. ePROGESA and eRisk Line together provide the next Plasma Collection Management Software solution providing unique features in accordance with European and International regulations and standards. MAK-SYSTEM’s rich solutions are currently implemented in over 40 countries, including 22 nationwide installations. Our global infrastructure and distribution network provide the capacity and capability to help ensure we can serve our clients to the highest standards wherever they are located around the globe.

MAK-SYSTEM International Group, 10 avenue de la Grande Armée, FR-75017 Paris, phone: +33 1 44 09 04 04, e-mail : This e-mail address is being protected from spam bots, you need JavaScript enabled to view it , website: www.mak-system.net